Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
23.59
-4.40 (-15.72%)
At close: Apr 1, 2025, 4:00 PM
26.34
+2.75 (11.67%)
After-hours: Apr 1, 2025, 4:26 PM EDT

Palvella Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
-18.69-27.55
Stock-Based Compensation
-0.60.43
Other Operating Activities
--29.8510.66
Change in Accounts Payable
--2.251.98
Change in Other Net Operating Assets
--0.9-0.36
Operating Cash Flow
--13.7-14.84
Long-Term Debt Issued
-5-
Net Debt Issued (Repaid)
-5-
Issuance of Common Stock
--0.03
Financing Cash Flow
-59.57
Net Cash Flow
--8.7-5.27
Levered Free Cash Flow
--9.96-
Unlevered Free Cash Flow
--9.96-
Change in Net Working Capital
-5.243.15-
Updated Dec 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q